Abstract

The ADAMs (a disintegrin and metalloprotease) are a family of multidomain proteins with structural homology to snake venom metalloproteases. We recently described the cloning and sequencing of human ADAM 12 (meltrin alpha). In this report we provide evidence that the metalloprotease domain of ADAM 12 is catalytically active. We used the trapping mechanism of alpha2-macroglobulin to assay for protease activity of wild-type and mutant ADAM 12 proteins produced in a COS cell transfection system. We found that ADAM 12 is synthesized as a zymogen, with the prodomain maintaining the metalloprotease in a latent form, probably by means of a cysteine switch. The zymogen could be activated chemically by alkylation with N-ethylmaleimide. Cleavage of the prodomain at a site for a furin-like endopeptidase resulted in an ADAM 12 protein with proteolytic activity. The protease activity was sensitive to inhibition by 1,10-phenanthroline and could be eliminated by mutation of the critical glutamate residue at the active site. The demonstration that the ADAM 12 metalloprotease domain is functional may have important implications for future studies that explore the role of ADAM 12 protein in development and disease.

Highlights

  • The ADAMs1 are a family of integral membrane or secreted glycoproteins comprised of several distinct domains

  • By site-directed mutagenesis, we altered critical amino acid residues of ADAM 12 chosen on the basis of structural comparisons with other members of the reprolysin family, expressed the mutant proteins in COS cells, and tested for reactivity with ␣2M

  • We have shown that ADAM 12-S is synthesized as a latent metalloprotease

Read more

Summary

Introduction

The ADAMs1 are a family of integral membrane or secreted glycoproteins comprised of several distinct domains. Selection of ADAM 12 Functional Motifs to Be Tested in a COS Cell Expression System—Sequence comparison of ADAM 12 with other reprolysins and with MMPs reveals that the ADAM 12 metalloprotease domain contains the zinc binding sequence that characterizes the active site of the these proteases (Fig. 1).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call